Welcome to the FDA Side Effects Update. This series is designed to keep you informed about the latest safety advisories and newly documented side effects of your medications. In this installment, we’re highlighting safety updates concerning Transderm Scop, Caprelsa, Depakote, Hyzaar, Lamictal, and Xarelto. Transderm Scop (active ingredient: scopolamine) transdermal patch Initial FDA Approval: 1979 ... Read More